 |
May 13, 2010
First Orally Bioavailable Anti-Obesity/Diabetes Peptide
Drug Candidate to be Presented at the Endocrine Society
Annual Meeting in San Diego, June 19-22, 2010
|
|
January 28, 2010
"Zelos Therapeutics Initiates Dosing in a Phase 1 Clinical
Study of Nasal Spray Teriparatide"
|
|
January 25, 2010
"Aegis Therapeutics and Dr. Reddy’s Announce Strategic Alliance"
|
|
December 1, 2009
Aegis Therapeutics and Roche Enter into a License
Agreement for ProTek® Stabilization
|
|
September 15, 2009
Aegis Therapeutics to Present at the 4th Annual Peptide Therapeutics Symposium, November 17 – 18, 2009
|
|
August 26, 2009
Aegis Therapeutics and Albany Medical College Expand Collaboration for Novel Oral Anti-Obesity Drug
|
|
January 12, 2009
New Interferon Formulations Promise to Eliminate Injections in Multiple Sclerosis Treatment
|
|
January 6, 2009
Aegis Therapeutics’ Intravail® Technology Selected as Winner in Pharmaceutical Technology's “Innovations in Pharma Science Awards” for 2008
|
|
November 12, 2008
Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail® Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti Obesity Peptide
|
|
September 16, 2008
Aegis Therapeutics Awarded Patent for its ProTek® Room Temperature Stable Human Growth Hormone Formulations Suitable for Metered Nasal Spray Delivery
|
|
September 8, 2008
Aegis Therapeutics to Present at the “4th Modern Drug Discovery & Development Summit” in San Diego, CA, October 15-17, 2008
|
|
August 21, 2008
Aegis Therapeutics to Present at the “13th Annual Drug
Delivery Summit” in New Brunswick, NJ, September 22-23, 2008
|
|
April 16, 2008
Zelos Therapeutics and Aegis Therapeutics Announce
Collaboration for Intranasal Delivery of Zelos’ ZT-031
|
|
November 1, 2007
Aegis Therapeutics to Present at the “3rd Modern Drug
Discovery & Development Summit” in San Francisco,
November 30, 2007 |
|
April 4, 2007
Aegis Therapeutics to Present at the “C21 BioVentures
Conference” in Monterey California in May 2007 |
|
April 3, 2007
Aegis Therapeutics to Present Intravail® and ProTek®
Technologies at the “Drug Delivery 2007 Conference” in
San Francisco on April 10, 2007 |
|
March 1, 2007
Aegis Therapeutics To Introduce Its Cedar Therapeutics
Inc. Spin-out Company at the Frost and Sullivan Venture
Connections 2007 Symposium in San Francisco |
|
November 16, 2006
Aegis Therapeutics to Present at the “2nd Modern Drug
Discovery & Development Summit” in Philadelphia in
December 2006 |
|
November 15, 2006
Aegis’ Intravail® Technology Provides Effective
Oral Delivery of Anti-Sense Drugs in Primates |
|
July 24, 2006
Aegis Therapeutics to Present at the “5th Annual
Intranasal, Inhaled, and Pulmonary Drug Development
and Delivery Symposium” in October 2006 |
|
July 17, 2006
Aegis Therapeutics Announces Successful Human Clinical
Study Results for Intravail® |
|
July 10, 2006
Aegis Therapeutics’ ProTek™ Formulation Technology
Increases Stability and Reduces Immunogenicity of Protein
and Peptide Therapeutics |
|
March 20, 2006
Aegis Therapeutics to Present at the “TIDES” and “Drug
Delivery 2006” Conferences in May 2006 |
|
October 12, 2005
Aegis Therapeutics Files Second Drug Master File with FDA |
|
August 29, 2005
Aegis Therapeutics to Present Intravail™ Drug Delivery
Technology at CBI’s “Protein Drugs” Conference |
|
August 15, 2005
Aegis Therapeutics Invited to Present Intravail™ Drug
Delivery Technology and Participate in Panel Session at
SRI’s “Peptides and Therapeutic Proteins Conference” |
|
August 8, 2005
Aegis Therapeutics Files First Drug Master File with the FDA |
|
August 1, 2005
Aegis Therapeutics’ Intravail™ Drug Delivery
Technology Gaining Acceptance |
|
July 18, 2005
Aegis Therapeutics Invited to Present at the Health Care
Ventures 2005 Conference |
|
July 11, 2005
Aegis Therapeutics Invited to Participate in Panel
Session at 10th Anniversary - Drug Delivery
Technologies & Deal-Making Summit |
|
July 5, 2005
Aegis Therapeutics Invited to Participate in 2006 Gordon
Research Conference on Peptides |
|
June 20, 2005
Intranasal Technology, Inc. and Aegis Therapeutics expand on
their collaborative agreement and will pursue intranasal heparin and
ß-interferon using Aegis' Intravail™ Drug Delivery Technology |
|
June 13, 2005
Aegis Therapeutics Presents Overview of Recent Advances in
Intranasal Drug Delivery of Peptide and Protein Therapeutics in
PharmaVentures' Drug Delivery Companies Report, Spring/Summer
2005 Edition |
|
June 6, 2005
Aegis Therapeutics Initiates Feasibility Studies for Intranasal Drug
Delivery in Type 2 Diabetes and a Second Undisclosed Metabolic Disease |
|
May 16, 2005
Aegis Therapeutics and Albany Medical College
Combine Discoveries to Create a Novel Anti-Obesity Nasal Spray |
|
April 13, 2005
Intranasal Technology, Inc. Licenses Aegis Therapeutics'
Intravail™ Drug Delivery Technology |
|
January 4, 2005
Cam L. Garner Joins Aegis Board |
|
|
|
|
|
|
|
|
